Dr. Michael Fehlings: The Sodium-Glutamate Antagonist Riluzole Improves Outcome after Acute Spinal Cord Injury
To be published in EBioMedicine: "The Sodium-Glutamate Antagonist Riluzole Improves Outcome after Acute Spinal Cord Injury: Results from the RISCIS Randomised Controlled Trial Analysed Using a Global Statistical Analytic Technique"
Dr. Michael Fehlings: Augmenting AMPA receptor signaling following spinal cord injury increases ependymal-derived stem/progenitor cell (epNSPC) migration and promotes functional recovery
To be published in Nature Neuroscience: "Augmenting AMPA receptor signaling following spinal cord injury increases ependymal-derived stem/progenitor cell (epNSPC) migration and promotes functional recovery"
Dr. Agostino Pierro: Impairment of stromal-epithelial regenerative cross-talk in Hirschsprung disease primes for the progression to enterocolitis
To be published in Science Translational Medicine: “Impairment of stromal-epithelial regenerative cross-talk in Hirschsprung disease primes for the progression to enterocolitis"
Dr. Trevor W. Reichman: Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
Authors: Trevor W. Reichman, M.D., James F. Markmann, M.D., Ph.D., Jon Odorico, M.D., Piotr Witkowski, M.D., Ph.D. https://orcid.org/0000-0002-4459-6673, John J. Fung, M.D., Ph.D., Martin Wijkstrom, M.D., Fouad Kandeel, M.D., Ph.D., +13 , for the VX-880-101 FORWARD Study Group*Author Info & Affiliations
